Investment Rating - The report upgrades the investment rating of the company to "Buy-A" [1][8] Core Viewpoints - The company has secured Maxeon patent authorization, enhancing its overseas market expansion and establishing a strong technical barrier with its BC technology [3][4] - The BC technology offers significant cost advantages, outperforming TOPCon in terms of non-silicon costs and providing higher efficiency and reliability [4][6] - The company maintains the highest efficiency in ABC components, achieving a record of 24.8% in mass production efficiency as of December 2025 [5][62] - The company has seen substantial growth in orders, with a 400% year-on-year increase in N-type ABC component shipments in the first half of 2025 [7][78] Summary by Sections Market Performance - As of February 12, 2026, the closing price of the company's stock is 14.63 CNY per share, with a total market capitalization of 264.59 billion CNY [2] Financial Data and Forecast - The company is projected to achieve total revenue of 187.6 billion CNY, 269.5 billion CNY, and 378.4 billion CNY for the years 2025, 2026, and 2027, respectively, with year-on-year growth rates of 68.2%, 43.7%, and 40.4% [8][9] - The net profit forecast for the same years is -15.1 billion CNY, 11.5 billion CNY, and 28.5 billion CNY, with corresponding growth rates of 71.6%, 176.2%, and 147.7% [8][9] Technology and Product Advantages - The BC technology is recognized for its high efficiency, aesthetic appeal, and reliability, with a theoretical efficiency of up to 29.1% [4][40] - The company’s ABC components demonstrate a 6%-10% higher power generation compared to TOPCon components in various scenarios [7][69] - The company has a strong order backlog, with approximately 10GW of new orders in the first half of 2025, indicating robust demand for its products [7][78] Industry Position and Competitive Landscape - The company is positioned as a leader in the BC technology space, with a growing ecosystem and collaboration among over 20 enterprises entering the BC route [4][57] - The BC components are priced at a premium of over 10% compared to TOPCon, reflecting their advanced technology and market positioning [47]

Core Insights - The report highlights strong growth in capital expenditures in North America, particularly in the AI new materials sector, suggesting investment opportunities in upstream developments [5][6] - The report indicates that the new materials index fell by 1.53%, outperforming the ChiNext index by 1.76%, with various sub-sectors showing mixed performance [5] Market Performance - The report provides a summary of the domestic market indices, noting the closing values and percentage changes for major indices such as the Shanghai Composite Index and Shenzhen Component Index [4] - The new materials sector experienced a decline, with specific indices like semiconductor materials and electronic chemicals showing significant drops of 3.70% and 1.61% respectively [5] Price Tracking - Weekly price tracking of various materials shows fluctuations, with amino acids like valine decreasing by 1.42% to 13,850 RMB/ton, while vitamin E increased by 2.70% to 57,000 RMB/ton [5] - Prices for biodegradable materials remained stable, with PLA and PBS prices unchanged, indicating a steady market for these products [5] Investment Recommendations - The report recommends focusing on AI new materials due to the anticipated increase in demand driven by major cloud service providers like Amazon AWS, Microsoft, Google, and Meta, whose combined capital expenditures are projected to exceed $670 billion in 2026, a year-on-year increase of over 60% [5] - Specific companies are highlighted for potential investment, including Shengquan Group and Dongcai Technology in the resin sector, and Zhongcai Technology and Honghe Technology in the electronic fabric sector [5][6]

Investment Rating - The report maintains a rating of "Outperform" for the new materials sector, indicating a positive outlook for investment opportunities in this industry [2]. Core Insights - The new materials sector has experienced a decline, with the new materials index dropping by 1.53%, outperforming the ChiNext index by 1.76%. Over the past five trading days, various sub-sectors showed mixed performance, with battery chemicals slightly increasing by 0.09% while semiconductor materials fell by 3.70% [3][17]. - Strong capital expenditure growth is observed in North America, particularly among major cloud service providers like Amazon AWS, Microsoft, Google, and Meta, with a combined capital expenditure exceeding $670 billion in 2026, representing a year-on-year growth of over 60%. This investment is expected to drive demand for AI servers and related materials [6]. Summary by Sections 1. Secondary Market Performance - The new materials sector has seen a decline, with the Shanghai Composite Index and ChiNext Index also experiencing negative movements. The new materials index's performance is highlighted as it has outperformed the ChiNext index [3][13]. 2. Industry Chain Data Tracking - Price tracking for various materials shows fluctuations, with amino acids like valine at 13,850 RMB/ton (-1.42%) and vitamins such as vitamin A at 60,500 RMB/ton (-1.63%). Prices for biodegradable plastics remain stable, indicating a steady market for these materials [4][12]. 3. Industry News - The report emphasizes the importance of AI infrastructure development, which is expected to enhance the demand for high-frequency and high-speed copper-clad laminates and related materials. Companies such as Shengquan Group and Dongcai Technology are highlighted for their potential in the resin sector, while Zhongcai Technology and Honghe Technology are noted for electronic fabrics [6]. 4. Investment Recommendations - The report suggests focusing on upstream material development opportunities, particularly in AI-related sectors, as the demand for advanced materials is anticipated to grow significantly due to the increasing need for AI server infrastructure [5][6].

Market Trends - The domestic market indices showed slight fluctuations, with the Shanghai Composite Index closing at 4,128.37, up by 0.13% [4] - During the period from February 2 to February 8, major indices experienced declines, with the Shanghai Composite Index down by 1.27% and the ChiNext Index down by 3.28% [7] Industry Insights - The non-bank financial sector is seeing a revision in underwriting regulatory guidelines, which is expected to enhance investment value in the sector [5] - The media industry is projected to continue its upward trend, driven by AI applications and IP ecosystems, with a 27.17% increase in the media index for 2025 [6] - The power equipment and new energy sector is focusing on the AIDC power revolution, with expectations for a significant increase in photovoltaic power utilization rates [8][19] - The agricultural sector is facing potential price adjustments in pig farming after a peak season, with current prices showing a downward trend [15][17] Company Analysis - Aide Technology is recognized as a leader in domestic spinal vertebral body shaping systems, benefiting from an aging population [22] - Tianfu Communication's 2025 performance forecast indicates a net profit of 1.88 to 2.15 billion yuan, driven by stable demand for optical devices [26] - Wolong Nuclear Materials anticipates a net profit of 1.1 to 1.18 billion yuan for 2025, with strong market demand across various business segments [28] Investment Recommendations - The report suggests focusing on companies that leverage AI applications and IP development, such as Kunlun Wanwei and Shanghai Film [9] - In the photovoltaic sector, companies like Aishuo and Longji Green Energy are recommended due to their technological advancements and market positioning [16][23] - For the copper connection market, companies like Wolong Nuclear Materials are highlighted for their strong growth potential in the telecommunications sector [28]

2026 年 2 月 10 日 行业研究/行业周报 非银行金融行业近一年市场表现 资料来源：常闻 【山证非银行金融】建设金融强国，关 注板块投资价值-【山证非银】行业周报 （20260126-20260201）： 2026.2.5 【山证非银行金融】公募业绩基准出台， 关注板块投资价值-【山证非银】行业周 报（20260119-20260125）： 2026.1.29 分析师： 刘丽 执业登记编码：S0760511050001 电话：0351--8686985 邮箱：liuli2@sxzq.com 孙田田 执业登记编码：S0760518030001 电话：0351-8686900 邮箱：suntiantian@sxzq.com 彭皓辰 执业登记编码：S0760525060001 邮箱：penghaochen@sxzq.com 非银行金融 行业周报（20260202-20260208） 领先大市-A(维持)) 修订发行承销监管指引，关注板块投资价值 投资要点 相关报告： 沪深交易所修订发行承销违规行为监管指引。沪深交易所分别 修订了《发行承销违规行为监管指引》，完善监管标准与违规情形， 提升发行承销监管的规范性 ...

Investment Rating - The report assigns a rating of "Buy" for the company, indicating an expected price increase of over 15% compared to the benchmark index within 6-12 months [58]. Core Insights - The company, Aide Technology, is a leading domestic player in the spinal vertebral body shaping system, benefiting from the aging population and increasing demand for orthopedic medical devices [3][28]. - The orthopedic implant medical device industry is projected to reach a market size of 24.6 billion yuan in 2024, driven by the aging population and increasing treatment penetration rates [4][36]. - The company has established a comprehensive product matrix covering 132 products across various orthopedic fields, including spinal, trauma, and sports medicine [5][35]. Summary by Sections Market Data - Total share capital is 0.89 billion shares [1]. Financial Data - The company is expected to achieve revenues of 2.86 billion yuan, 2.62 billion yuan, 2.75 billion yuan, and 3.02 billion yuan from 2022 to 2025, with year-on-year growth rates of -4.11%, -8.22%, 4.87%, and 9.74% respectively [6][47]. - Net profit for the same period is projected to be 9327.94 million yuan, 6356.86 million yuan, 6713.05 million yuan, and 7775.27 million yuan, with growth rates of -0.21%, -31.85%, 5.60%, and 15.82% respectively [6][47]. Company Overview - Aide Technology focuses on the research, production, and sales of orthopedic consumables, including spinal, trauma, and sports medicine products [3][28]. - The company has been recognized as a national high-tech enterprise and has received various accolades, including "Jiangsu Province Specialized and Innovative Small and Medium Enterprises" [3][28]. Competitive Advantages - The company has a well-established national sales network and a deep communication mechanism with hospitals and orthopedic doctors, enhancing product recognition and market penetration [5][35]. - Aide Technology has obtained 108 patents, with a research and development investment ratio of 6.96% from 2022 to 2024, indicating a strong commitment to innovation [5][35]. Market Trends - The demand for orthopedic implants is driven by a high prevalence of osteoporosis and vertebral compression fractures among the elderly population, with over 32% of individuals aged 65 and above affected [4][36]. - The company is adapting to the normalized procurement policies by promoting non-procurement products, which have shown steady growth, partially offsetting the revenue decline from procurement products [47]. Valuation Analysis - The company's projected price-to-earnings (PE) ratio for 2024 is 13.50, which is at a discount compared to comparable companies in the industry, whose average PE is 57.78 [25][26].

资料来源：常闻 | 首选股票 | | 评级 | | --- | --- | --- | | 300418.SZ | 昆仑万维 | 买入-A | | 601595.SH | 上海电影 | 买入-A | | 603258.SH | 电魂网络 | 增持-A | 相关报告： 潘宁河 执业登记编码：S0760523110001 邮箱：panninghe@sxzq.com 林挺 执业登记编码：S0760524100003 邮箱：linting@sxzq.com 传媒 行业年度策略报告 领先大市-A(维持) AI 应用+IP 生态双轮驱动，行业基本面有望持续向好 2026 年 2 月 10 日 行业研究/行业年度策略 投资要点： 传媒业绩增速向上，AI、游戏驱动指数上涨。2025 年全年，传媒指数 累计上涨 27.17%，位于申万 31 个一级子行业的第 9 名。传媒子板块中，游 戏、电视广播涨幅分别为 60.50%、20.80%，涨幅较为领先。2025 年 Q1-Q3， 传媒行业实现营收 3872.78 亿元，同比+5.75%；实现归母净利润 321.09 亿元， 同比+37.88%。子板块中，影视、游戏行业板块利润表现 ...

Investment Rating - The report assigns a rating of "Buy" for the company, indicating an expected price increase exceeding 15% relative to the benchmark index within 6-12 months [58]. Core Insights - The company, Aide Technology, is a leading domestic player in the spinal vertebral body shaping system, benefiting from the aging population and increasing demand for orthopedic medical devices [3][28]. - The orthopedic implant medical device industry is projected to reach a market size of 24.6 billion yuan in 2024, driven by the aging population and increasing treatment penetration rates [4][36]. - The company has established a comprehensive product matrix covering 132 items across various orthopedic fields, including spinal, trauma, and sports medicine [5][35]. Summary by Sections Market Data - Total share capital is 0.89 billion shares [1]. Financial Data - The company is expected to achieve revenues of 2.86 billion yuan, 2.62 billion yuan, 2.75 billion yuan, and 3.02 billion yuan from 2022 to 2025, with year-on-year growth rates of -4.11%, -8.22%, 4.87%, and 9.74% respectively [6][47]. - Net profit for the same period is projected to be 93.28 million yuan, 63.57 million yuan, 67.13 million yuan, and 77.75 million yuan, with growth rates of -0.21%, -31.85%, 5.60%, and 15.82% respectively [6][47]. - The company's gross margin is expected to be 62.45%, 57.80%, 58.05%, and 58.90% from 2022 to 2025 [50]. Business Overview - Aide Technology focuses on the research, production, and sales of orthopedic consumables, including spinal, trauma, and sports medicine products [3][28]. - The company has been recognized as a national high-tech enterprise and has received various accolades, including "Jiangsu Province Specialized and Innovative Small and Medium-sized Enterprises" [3][28]. Competitive Position - The company ranks third among domestic manufacturers of spinal vertebral body shaping systems and sixth among spinal implant manufacturers [3][28]. - Aide Technology has a well-established national sales network and a strong communication mechanism with hospitals and orthopedic surgeons, enhancing product recognition and market penetration [5][35]. Investment Analysis - The company is positioned to benefit from the ongoing trend of centralized procurement in the industry, which is expected to normalize pricing and enhance market opportunities [4][36]. - The company’s revenue from non-procurement products is growing, helping to offset declines in procurement product revenues [47]. Use of Proceeds - The company plans to use the proceeds from its public offering for expanding orthopedic consumables production, building a research center, and enhancing its marketing network [53][54].

Group 1: AIDC and Power Supply Innovations - The global AIDC demand is experiencing significant growth, with major cloud companies increasing their capital expenditures. In FY2025, the top three global cloud providers are expected to collectively spend nearly $300 billion [3][19] - High Voltage Direct Current (HVDC) is becoming the preferred solution for next-generation data center power supply, as it enhances power efficiency and reduces material usage. The global HVDC market is projected to reach approximately $30 billion by 2027 [4][59] - Key recommendations for HVDC and Storage Solutions include companies like Zhongheng Electric and Siyuan Electric, with additional attention on Keda Data, Kstar, and others [10][65] Group 2: Photovoltaic Industry Trends - The photovoltaic industry is transitioning towards high-quality development, with supply-demand dynamics expected to gradually improve. In 2025, domestic photovoltaic installations are projected to reach a record high, although global installation growth is anticipated to slow down post-2026 [5][6] - The industry is actively reducing operating rates to improve supply-demand structures, with significant declines in operating rates for polysilicon and other segments noted [6][7] - Key recommendations in the photovoltaic sector focus on supply-side improvements and new technologies, with companies like Flat Glass and Quartz Holdings highlighted for their potential [11][10]

Investment Rating - The industry investment rating is maintained at "Synchronize with the market - A" [1] Core Insights - SpaceX's application for deploying a satellite system with up to 1 million satellites has been accepted by the FCC, which aims to support advanced AI models and related applications [2] - The utilization rate of photovoltaic power generation is projected to reach 94.8% by 2025, with wind power utilization at 94.3% [3] - The National Energy Administration announced that by December 2025, there will be 6,190 new registered photovoltaic power generation projects [4] Summary by Relevant Sections Stock Recommendations - Recommended stocks include: - Aishuo Co., Ltd. (600732.SH) - Buy - B - Flat Glass Group (601865.SH) - Buy - A - Haibo Technology (688411.SH) - Buy - A - Sungrow Power Supply (300274.SZ) - Buy - A - Longxin Technology (300682.SZ) - Buy - B - Quartz Co., Ltd. (603688.SH) - Buy - A [3][4] Market Performance - The report indicates a 7.4% year-on-year increase in the national electricity market transaction volume by 2025 [4] - The report highlights a stable price trend for polysilicon, silicon wafers, battery cells, and modules, with no significant fluctuations observed [5][7][8] Investment Suggestions - Key investment directions include: - BC new technology: Aishuo Co., Ltd. - Supply-side focus: Daqo New Energy, Flat Glass Group - Energy storage direction: Haibo Technology, Sungrow Power Supply - Market-oriented direction: Longxin Group - Domestic substitution direction: Quartz Co., Ltd. - Attention to space photovoltaic: Liancheng CNC, Dike Co., Ltd., Longi Green Energy, and others [9]